TriSalus Life Sciences Price to Free Cash Flow Ratio 2021-2024 | TLSI
Historical price to free cash flow ratio values for TriSalus Life Sciences (TLSI) since 2021.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| TriSalus Life Sciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-02 | 5.11 | 0.00 | |
| 2024-12-31 | 5.01 | $-1.63 | 0.00 |
| 2024-09-30 | 4.61 | $-3.62 | 0.00 |
| 2024-06-30 | 5.52 | $37.88 | 0.15 |
| 2024-03-31 | 9.75 | $-5.26 | 0.00 |
| 2023-12-31 | 8.45 | $-5.45 | 0.00 |
| 2023-09-30 | 5.12 | $-31.09 | 0.00 |
| 2023-06-30 | 10.48 | $-150.51 | 0.00 |
| 2023-03-31 | 10.20 | $-106.93 | 0.00 |
| 2022-12-31 | 10.03 | $-106.35 | 0.00 |
| 2022-09-30 | 9.93 | $-78.53 | 0.00 |
| 2022-06-30 | 9.85 | $-0.35 | 0.00 |
| 2022-03-31 | 9.80 | $-0.31 | 0.00 |
| 2021-12-31 | 9.88 | $-0.28 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.165B | $0.029B |
| TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO. | |||